Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060311HBVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30087023HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS30074133HIVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007384HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20007385HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20004195HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20065658HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20043075HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20024956HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS20034877HPVENSG00000171105.14protein_codingINSRYesNo3643P06213
TCGA Plot Options
Drug Information
GeneINSR
DrugBank IDDB00047
Drug NameInsulin glargine
Target IDBE0000033
UniProt IDP06213
Regulation Typeagonist
PubMed IDs11752352; 17922476; 20424816; 18585815
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Le Roith D: Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes. Diabetes Metab Res Rev. 2007 Nov;23(8):593-9.@@Sciacca L, Cassarino MF, Genua M, Pandini G, Le Moli R, Squatrito S, Vigneri R: Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia. 2010 Aug;53(8):1743-53. doi: 10.1007/s00125-010-1760-6. Epub 2010 Apr 28.@@Wada T, Azegami M, Sugiyama M, Tsuneki H, Sasaoka T: Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin. Diabetes Res Clin Pract. 2008 Sep;81(3):269-77. doi: 10.1016/j.diabres.2008.05.007. Epub 2008 Jun 27.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA449992
ChEMBLCHEMBL1201497